Business Description
Redhill Biopharma Ltd
NAICS : 325412
ISIN : US7574681034
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 13.04 | |||||
Debt-to-Equity | 9.15 | |||||
Debt-to-EBITDA | 0.01 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -17.84 | |||||
Beneish M-Score | 10.88 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -75.8 | |||||
3-Year EPS without NRI Growth Rate | 72.1 | |||||
3-Year FCF Growth Rate | 63.5 | |||||
3-Year Book Growth Rate | -80.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.34 | |||||
9-Day RSI | 44.13 | |||||
14-Day RSI | 45.63 | |||||
6-1 Month Momentum % | -11.78 | |||||
12-1 Month Momentum % | -23.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.74 | |||||
Quick Ratio | 0.56 | |||||
Cash Ratio | 0.34 | |||||
Days Inventory | 660.76 | |||||
Days Sales Outstanding | 145.86 | |||||
Days Payable | 417.73 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -173.7 | |||||
Shareholder Yield % | 545.13 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.18 | |||||
Operating Margin % | -339.59 | |||||
Net Margin % | 945.36 | |||||
FCF Margin % | -328.47 | |||||
ROE % | 2731.76 | |||||
ROA % | 191 | |||||
ROIC % | -82.71 | |||||
3-Year ROIIC % | -27.85 | |||||
ROC (Joel Greenblatt) % | 3949.83 | |||||
ROCE % | 1398.28 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 0.02 | |||||
PE Ratio without NRI | 0.02 | |||||
PS Ratio | 0.17 | |||||
PB Ratio | 170.83 | |||||
EV-to-EBIT | 0.07 | |||||
EV-to-EBITDA | 0.03 | |||||
EV-to-Forward-EBITDA | -3.75 | |||||
EV-to-Revenue | 0.7 | |||||
EV-to-Forward-Revenue | 1.37 | |||||
EV-to-FCF | -0.21 | |||||
Earnings Yield (Greenblatt) % | 1428.57 | |||||
FCF Yield % | -169.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Redhill Biopharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 5.019 | ||
EPS (TTM) (€) | 471.455 | ||
Beta | 5.68 | ||
Volatility % | 370.73 | ||
14-Day RSI | 45.63 | ||
14-Day ATR (€) | 0.037915 | ||
20-Day SMA (€) | 8.2375 | ||
12-1 Month Momentum % | -23.73 | ||
52-Week Range (€) | 6.3375 - 90 | ||
Shares Outstanding (Mil) | 1.28 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Redhill Biopharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Redhill Biopharma Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Redhill Biopharma Ltd Frequently Asked Questions
What is Redhill Biopharma Ltd(STU:2RH)'s stock price today?
When is next earnings date of Redhill Biopharma Ltd(STU:2RH)?
Does Redhill Biopharma Ltd(STU:2RH) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |